Type 1 Diabetes: Living With the Disease

References

Citations

1. Rewers A, et al. (2002). Predictors of acute complications in children with type 1 diabetes. JAMA, 287(19): 2511–2518.

2. American Diabetes Association (2004). Retinopathy in diabetes. Clinical Practice Recommendations 2004. Diabetes Care, 27(Suppl 1): S84–S87.

3. American Diabetes Association (2004). Nephropathy in diabetes. Clinical Practice Recommendations 2004. Diabetes Care, 27(Suppl 1): S79–S83.

4. American Diabetes Association (2004). All About Diabetes. Available online: http://www.diabetes.org/about-diabetes.jsp.

5. Zochodne DW (2001). Peripheral nerve disease. In HC Gerstein, RB Haynes, eds., Evidence-Based Diabetes Care, pp. 466–487. Hamilton, ON: BC Decker.

6. American Diabetes Association (2004). Aspirin therapy in diabetes. Clinical Practice Recommendations 2004. Diabetes Care, 27(Suppl 1): S72–S73.

7. Canadian Diabetes Association (2003). Macrovascular complications, dyslipidemia, and hypertension. Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Canadian Journal of Diabetes, 27(2, Suppl): S58–S65.

8. American Diabetes Association (2004). Hyperglycemic crises in diabetes. Clinical Practice Recommendations 2004. Diabetes Care, 27(Suppl 1): S94–S102.

9. Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group (2001). Beneficial effects of intensive therapy of diabetes during adolescence: Outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). Journal of Pediatrics, 139(6): 804–812.

10. Sigal R, et al. (2005). Prevention of cardiovascular events in diabetes, search date May 2006. Online version of Clinical Evidence (14): 1–23.

11. American Diabetes Association (2004). Smoking and diabetes. Clinical Practice Recommendations 2004. Diabetes Care, 27(Suppl 1): S74–S75.

12. American Diabetes Association (2003). Low-glycemic index diets in the management of diabetes: A meta-analysis of randomized controlled trials. Diabetes Care, 26(8): 2261–2267.

13. American Diabetes Association (2004). Hypertension management in adults with diabetes. Clinical Practice Recommendations 2004. Diabetes Care, 27(Suppl 1): S65–S67.

14. ACE Inhibitors in Diabetic Nephropathy Trialist Group (2001). Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? Annals of Internal Medicine, 134(5): 370–379.

15. American Diabetes Association (2004). Dyslipidemia management in adults with diabetes. Clinical Practice Recommendations 2004. Diabetes Care, 27(Suppl 1): S68–S71.

16. Collins R, et al. (2003). MRC/BHF heart protection study of cholesterol-lowering with simvastatin in 5,963 people with diabetes: A randomised placebo-controlled trial. Heart Protection Study Collaborative Group. Lancet, 361(9374): 2005–2016.

17. Sutherland DE, et al. (2001). Lessons learned from more than 1,000 pancreas transplants at a single institution. Annals of Surgery, 233(4): 463–501.

Other Works Consulted

• American Diabetes Association (2000). Role of fat replacers in diabetes medical nutrition therapy. Clinical Practice Recommendations 2000. Diabetes Care, 23(Suppl 1): S96–S97.

• American Diabetes Association (2004). Influenza and pneumococcal immunization in diabetes. Position statement. Clinical Practice Recommendations 2004. Diabetes Care, 27(Suppl 1): S111–S113.

• Campbell A (2006). Glycaemic control in type 1 diabetes, search date May 2006. Online version of Clinical Evidence, (15): 1–11.

• Gerstein HC, et al. (2001). Cardiovascular disease. In HC Gerstein, RB Haynes, eds., Evidence-Based Diabetes Care, pp. 488–514. Hamilton, ON: BC Decker.

• Hill JV, Beaser RS (2001). Carbohydrate counting and Necessity of carbohydrate counting for patients using an insulin pump sections of Medical nutrition therapy. In RS Beaser et al., eds., Joslin's Diabetes Deskbook, pp. 90–92. Boston: Joslin Diabetes Center.

• Levine BS, et al. (2001). Predictors of glycemic control and short-term adverse outcomes in youth with type 1 diabetes. Journal of Pediatrics, 139(2): 197–203.

• Ludwig DS (2002). The glycemic index: Physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA, 287(18): 2414–2423.

• Pickup J, Keen H (2002). Continuous subcutaneous insulin infusion at 25 years. Diabetes Care, 25(30): 593–598.

Go to previous section	Go to top of page	Go to next section
Author:	Alison Allen Robin Parks, MS	Last Updated: February 23, 2007
Medical Review:	Caroline S. Rhoads, MD - Internal Medicine Matthew I. Kim, MD - Endocrinology & Metabolism Donald Sproule, MD, CM, CCFP, FCFP - Family Medicine
© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.